Impact of the dead-time correction method on quantitative 177Lu-SPECT (QSPECT) and dosimetry during radiopharmaceutical therapy

被引：0
|
作者：
Alessandro Desy
Guillaume F. Bouvet
Nancy Lafrenière
Atefeh Zamanian
Philippe Després
Jean-Mathieu Beauregard
机构：
[1] CHU de Québec – Université Laval,Department of Medical Imaging, and Research Centre (Oncology Axis)
[2] Université Laval,Department of Radiology and Nuclear Medicine, and Cancer Research Centre
[3] CHU de Québec – Université Laval,Department of Radiation Oncology, and Research Centre (Oncology Axis)
[4] Université Laval,Department of Physics, Physical Engineering and Optics, and Cancer Research Centre
来源：
EJNMMI Physics | / 9卷
关键词：
Quantitative imaging; Single-photon emission computed tomography; Dead time; Dosimetry; Lutetium-177; Radiopharmaceutical therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] An Original Segmentation Method for Dosimetry of Refractory Meningiomas Treated by 177Lu-DOTATATE based on Quantitative SPECT 360° Whole-body CZT- camera Imaging
    Zaragori, T.
    Boursier, C.
    Bros, M.
    Mairal, E.
    Verger, A.
    Imbert, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S642 - S642
  • [42] Single-time-point dosimetry for tumour lesions during [177Lu]Lu-PSMA-617 therapy using non-linear mixedeffects modeling
    Hardiansyah, D.
    Yousefzadeh-Nowshahr, E.
    Kind, F.
    Beer, A. J.
    Ruf, J.
    Mix, M.
    Glatting, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S71 - S72
  • [43] Biodistribution and dosimetry for combined [177Lu]Lu-PSMA-I&T/[225Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging
    Astrid Delker
    Mirjam Schleske
    Grigory Liubchenko
    Isabella Berg
    Mathias Johannes Zacherl
    Matthias Brendel
    Franz Josef Gildehaus
    Mikhail Rumiantcev
    Sandra Resch
    Kerstin Hürkamp
    Vera Wenter
    Lena M. Unterrainer
    Peter Bartenstein
    Sibylle I. Ziegler
    Leonie Beyer
    Guido Böning
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 1280 - 1290
  • [44] Biodistribution and dosimetry for combined [177Lu]Lu-PSMA-I&T/[225Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging
    Delker, Astrid
    Schleske, Mirjam
    Liubchenko, Grigory
    Berg, Isabella
    Zacherl, Mathias Johannes
    Brendel, Matthias
    Gildehaus, Franz Josef
    Rumiantcev, Mikhail
    Resch, Sandra
    Huerkamp, Kerstin
    Wenter, Vera
    Unterrainer, Lena M.
    Bartenstein, Peter
    Ziegler, Sibylle, I
    Beyer, Leonie
    Boening, Guido
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (05) : 1280 - 1290
  • [45] Radiation Dosimetry in 177Lu-PSMA-617 Therapy Using a Single Posttreatment SPECT/CT Scan: A Novel Methodology to Generate Time- and Tissue-Specific Dose Factors
    Jackson, Price A.
    Hofman, Michael S.
    Hicks, Rodney J.
    Scalzo, Mark
    Violet, John
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (07) : 1030 - 1036
  • [46] Kidney Dosimetry in 177Lu and 90Y Peptide Receptor Radionuclide Therapy: Influence of Image Timing, Time-Activity Integration Method, and Risk Factors
    Guerriero, F.
    Ferrari, M. E.
    Botta, F.
    Fioroni, F.
    Grassi, E.
    Versari, A.
    Sarnelli, A.
    Pacilio, M.
    Amato, E.
    Strigari, L.
    Bodei, L.
    Paganelli, G.
    Iori, M.
    Pedroli, G.
    Cremonesi, M.
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [47] Monte Carlo bone marrow dosimetry in radioligand therapy using patient-specific marrow and lesion localization from quantitative 99mTc-sulfur colloid and 177Lu-PSMA-617 SPECT/CT
    Peterson, Avery
    Wilderman, Scott
    Wong, Ka Kit
    Frey, Kirk
    Dewaraja, Yuni
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [48] Estimation of absorbed dose to salivary glands in mCRPC patients undergoing 177 Lu- PSMA-617 radioligand therapy using quantitative SPECT-CT at single time point: a single-center feasibility study
    Kaur, Komalpreet
    Nagi, Shreya
    Satapathy, Swayamjeet
    Aggarwal, Piyush
    Sood, Ashwani
    Mittal, Bhagwant Rai
    NUCLEAR MEDICINE COMMUNICATIONS, 2024, 45 (02) : 115 - 120
  • [49] Assessing the Impact of Dosimetry Method on Healthy organ and Lesion Absorbed Dose Estimates for 177Lu-PSMA-617 Therapy of Prostate Cancer: Early Experience from the Canadian Cancer Trials Group PR21 trial (NCT 04663997)
    Brosch-Lenz, J.
    Hou, X.
    Bloise, I.
    Colpo, N.
    Parulekar, W. R.
    Dellar, C.
    Saad, F.
    Chi, K.
    Wilson, D.
    Benard, F.
    Rahmim, A.
    Uribe, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S394 - S395
  • [50] Patient-specific dosimetry adapted to variable number of SPECT/CT time-points per cycle for 177\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$^{177}$$\end{document}Lu-DOTATATE therapy
    Laure Vergnaud
    Anne-Laure Giraudet
    Aurélie Moreau
    Julien Salvadori
    Alessio Imperiale
    Thomas Baudier
    Jean-Noël Badel
    David Sarrut
    EJNMMI Physics, 9 (1)
12345